Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment

Daphne S. Bakker; Julia Drylewicz; Stefan Nierkens; Edward F. Knol; Barbara Giovannone; Eveline M. Delemarre; Jorien van der Schaft; Deepak M.W. Balak; Marjolein S. de Bruin-Weller; Judith L. Thijs

doi:10.1111/cea.13495

Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment

Daphne S. Bakker, Julia Drylewicz, Stefan Nierkens, Edward F. Knol, Barbara Giovannone, Eveline M. Delemarre, Jorien van der Schaft, Deepak M.W. Balak, Marjolein S. de Bruin-Weller, Judith L. Thijs

Onderzoeksoutput: Bijdrage aan tijdschrift › Brief › peer review

4 Citaten (Scopus)

Originele taal-2	Engels
Pagina's (van-tot)	1641-1644
Aantal pagina's	4
Tijdschrift	Clinical and Experimental Allergy
Volume	49
Nummer van het tijdschrift	12
DOI's	https://doi.org/10.1111/cea.13495
Status	Gepubliceerd - 1 dec. 2019
Extern gepubliceerd	Ja

Toegang tot document

10.1111/cea.13495

Citeer dit

@article{b744a24001dc4e9a816ce4a1b746241f,

title = "Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment",

author = "Bakker, {Daphne S.} and Julia Drylewicz and Stefan Nierkens and Knol, {Edward F.} and Barbara Giovannone and Delemarre, {Eveline M.} and {van der Schaft}, Jorien and Balak, {Deepak M.W.} and {de Bruin-Weller}, {Marjolein S.} and Thijs, {Judith L.}",

note = "Funding Information: MS de Bruin-Weller: consultant for Regeneron Pharmaceuticals, Inc, Sanofi Genzyme; an advisory board member for AbbVie, Regeneron Pharmaceuticals, Inc, Sanofi Genzyme; and principal investigator for AbbVie, Regeneron Pharmaceuticals, Inc, Roche, Sanofi Genzyme. The other authors have no conflicts of interest to declare.",

year = "2019",

month = dec,

day = "1",

doi = "10.1111/cea.13495",

language = "English",

volume = "49",

pages = "1641--1644",

journal = "Clinical and Experimental Allergy",

issn = "0954-7894",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "12",

}

TY - JOUR

T1 - Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment

AU - Bakker, Daphne S.

AU - Drylewicz, Julia

AU - Nierkens, Stefan

AU - Knol, Edward F.

AU - Giovannone, Barbara

AU - Delemarre, Eveline M.

AU - van der Schaft, Jorien

AU - Balak, Deepak M.W.

AU - de Bruin-Weller, Marjolein S.

AU - Thijs, Judith L.

N1 - Funding Information: MS de Bruin-Weller: consultant for Regeneron Pharmaceuticals, Inc, Sanofi Genzyme; an advisory board member for AbbVie, Regeneron Pharmaceuticals, Inc, Sanofi Genzyme; and principal investigator for AbbVie, Regeneron Pharmaceuticals, Inc, Roche, Sanofi Genzyme. The other authors have no conflicts of interest to declare.

PY - 2019/12/1

Y1 - 2019/12/1

UR - http://www.scopus.com/inward/record.url?scp=85073994978&partnerID=8YFLogxK

U2 - 10.1111/cea.13495

DO - 10.1111/cea.13495

M3 - Letter

C2 - 31520450

AN - SCOPUS:85073994978

SN - 0954-7894

VL - 49

SP - 1641

EP - 1644

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

IS - 12

ER -